P. Traine, C. Scheib, J. Garweg
Choroidal Neovascularization Resulting from Angioid Streaks in Pseudoxanthoma Elasticum
2019, Ophthalmology Retina, 3(1):31. doi: 10.1016/j.oret.2018.10.007. PubMed PMID: 30929814
J. Garweg, S. Zandi, I. Pfister, R. Rieben, M. Skowronska, C. Tappeiner
Cytokine profiles of phakic and pseudophakic eyes with primary retinal detachment
18.12.2018, Acta ophthalmologica, . doi: 10.1111/aos.13998. [Epub ahead of print] PubMed
J. Spindler, S. Zandi, I. Pfister, C. Gerhardt, J. Garweg
Cytokine profiles in the aqueous humor and serum of patients with dry and treated wet age-related macular degeneration
29.8.2018, Public Library of Science, 13(8):e0203337. doi: 10.1371/journal.pone.0203337
H. Ahmadieh, R. Nourinia, A. Hafezi-Moghadam, H. Sabbaghi, S. Nakao, S. Zandi, M. Yaseri, Z. Tofighi, S. Akbarian
Intravitreal injection of a Rho-kinase inhibitor (fasudil) combined with bevacizumab versus bevacizumab monotherapy for diabetic macular oedema: a pilot randomised clinical trial
27.8.2018, The British journal of ophthalmology, pii: bjophthalmol-2018-312244. doi: 10.1136/bjophthalmol-2018-312244. [Epub ahead of print]
J. Garweg, J. Zirpel, C. Gerhardt, I. Pfister
Past and prognosis of anti-VEGF therapy for wet age-related macular degeneration-the future has begun
1.8.2018, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 256(8):1553-1555. doi: 10.1007/s00417-018-4005-x. Epub 2018 May 9. PubMed PMID: 29744574
P. Maloca, P. Hasler, D. Barthelmes, P. Arnold, M. Mooser, H. Scholl, H. Gerding, J. Garweg, T. Heeren, K. Balaskas, J. de Carvalho, C. Egan, A. Tufail, S. Zweifel
Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring
1.7.2018, Translational vision science and technology, 24 7(4):8. doi: 10.1167/tvst.7.4.8
J. Garweg
Macular Edema in Childhood Uveitis
1.4.2018, Klinische Monatsblätter für Augenheilkunde, 235:373-376
J. Garweg, J. Zirpel, C. Gerhardt, I. Pfister
The fate of eyes with wet AMD beyond four years of anti-VEGF therapy
1.4.2018, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 256(4):823-831. doi: 10.1007/s00417-018-3907-y
J. Garweg, M. Deiss, I. Pfister, C. Gerhardt
IMPACT OF INNER LIMITING MEMBRANE PEELING ON VISUAL RECOVERY AFTER VITRECTOMY FOR PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT INVOLVING THE FOVEA
1.2.2018, Retina (Philadelphia, Pa.), doi: 10.1097/IAE.0000000000002046
S. Zandi, B. Bodaghi, J. Garweg
Review for Disease of the Year: Treatment of Viral Anterior Uveitis: A Perspective
2018, Ocular immunology and inflammation, 26(7):1135-1142. doi: 10.1080/09273948.2018.1498109. Epub 2018 Aug 10
J. Garweg, S. Niderprim, H. Russ, I. Pfister
Comparison of Strategies of Treatment with Ranibizumab in Newly-Diagnosed Cases of Neovascular Age-Related Macular Degeneration
1.12.2017, Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, 33(10):773-778. doi: 10.1089/jop.2017.0006
S. Zandi, T. Lereuil, F. Freiberg, M. Pfau, I. Pfister, C. Gerhardt, A. Meyenberg, S. Michels, L. Kodjikian, J. Garweg
Long-Term Intravitreal Dexamethasone Treatment in Eyes with Pretreated Chronic Diabetic Macular Edema
1.10.2017, Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, 33(8):620-628. doi: 10.1089/jop.2017.0020
J. Garweg, M. Deiss, C. Gerhardt, L. Kodjikian, I. Pfister
Real-Life Experience with Aflibercept and Ranibizumab in the Treatment of Newly Diagnosed Neovascular Age-Related Macular Degneration over 24 Months
1.9.2017, Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, 33(7):567-572. doi: 10.1089/jop.2017.0031
J. Garweg, S. Zandi, I. Pfister, M. Skowronska, C. Gerhardt
Comparison of cytokine profiles in the aqueous humor of eyes with pseudoexfolation syndrome and glaucoma
10.8.2017, Public Library of Science, 12(8):e0182571. doi: 10.1371/journal.pone.0182571
R. Nourinia, S. Nakao, S. Zandi, S. Safi, A. Hafezi-Moghadam, H. Ahmadieh
ROCK inhibitors for the treatment of ocular diseases
9.8.2017, The British journal of ophthalmology, pii: bjophthalmol-2017-310378. doi: 10.1136/bjophthalmol-2017-310378
J. Garweg, S. Zandi, C. Gerhardt, I. Pfister
Isoforms of TGF-beta in the aqueous humor of patients with pseudoexfolation syndrome and a possible association with the long-term stability of the capsular bag after cataract surgery.
28.6.2017, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 255(9):1763-1769. doi: 10.1007/s00417-017-3724-8
S. Zandi, F. Weisskopf, J. Garweg, M. Imesch, I. Pfister, C. Prünte, F. Sutter, K. Hatz
Pre-Existing RPE Atrophy and Defects in the External Limiting Membrane Predict Early Poor Visual Response to Ranibizumab in Neovascular Age-Related Macular Degeneration
1.4.2017, Ophthalmic surgery, lasers & imaging: the official journal of the International Society for Imaging in the Eye, 48(4):326-332. doi: 10.3928/23258160-20170329-07
J. Garweg, H. Russ, I. Pfister
Early Response to Ranibizumab Is Predictive of Treatment Demand after a Therapeutic Switch to Aflibercept
2017, Ophthalmology, 1:210-216
J. Garweg, S. Niderprim, H. Russ, I. Pfister
Comparison of Strategies of Treatment with Ranibizumab in Newly-Diagnosed Cases of Neovascular Age-Realated Macular Degeneration.
1.12.2016, Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, 33:773-778
S. Zandi, C. Tappeiner, I. Pfister, A. Despont, R. Rieben, J. Garweg
Vitreal Cytokine Profile Differences Between Eyes With Epiretinal Membranes or Macular Holes
1.11.2016, Investigative ophthalmology & visual science, 57(14):6320-6326. doi: 10.1167/iovs.16-20657
